tirzepatide fda announcement Eli Lilly Gets Approval for Zepbound for Certain Sleep Apnea Patients The US-FDA has approved Tirzepatide
Description
World Health Organization issues first-ever guidelines for use of GLP-1 weight loss medications Globally, more than 1 billion people currently live with obesity

Both medications affect appetite, fullness, digestion, and metabolic signaling

The Long Covid risk of patients vaccinated after infection is also a cause of public health anxiety

Hormonal adaptation Tirzepatide affects multiple hormonal systems beyond insulin and glucagon
J Endocr Soc 8(Supplement1):bvae163 [Google Scholar] Rhea EM, Banks WA, Raber J (2022) Insulin resistance in peripheral tissues and the brain: a tale of two sites
